300 of the 1,024 Vault Cells are intended to be offered, beginning Q4 2027, to participants who complete TRELYAN's structured KYC/AML, sanctions-screening, and (where applicable) US-securities-accredited verification. Cells are structured with the intent of qualifying as Nutzungstoken (utility tokens) under FINMA's 2018 ICO Guidelines — utility-at-issuance, conjunctive transferability lock, per-buyer cap of two. Final classification is subject to FINMA pre-ruling and counsel review. The Stiftung is in formation in Zug under articles 80 to 89-bis of the Swiss Civil Code; supervision by the Eidgenössische Stiftungsaufsicht begins at registration.
Family-office and institutional tier. Earliest inscription right. Direct founder access. Priority feedback channel (non-binding, no governance right). 24-month transferability lock from genesis. Tier price indicative; subject to change.
Cryptography community and digital-asset professionals. Pre-publication research drafts. Early input on community-recognition Cells (non-binding). 24-month transferability lock.
Aligned individual tier. Per-buyer cap of two Cells, structurally enforced in the inscription contract. KYC/AML gated, application-order allocation, Stiftungsrat ratified.
Submitting this form is not an indication of intent to purchase, an offer to acquire any instrument, or a binding commitment of any kind. It is a request to be added to the Foundation's notification list and to be approached when the structured onboarding sequence opens in Q1 2027. Materials available under mutual NDA only.
Not an offer. This page is informational only. It is not an offer to sell, a solicitation of an offer to buy, or a recommendation regarding any security, token, or financial instrument. Nothing on this page constitutes legal, tax, investment, or accounting advice (the customary "NFA / DYOR" disclaimer). Tier prices and dates are indicative and subject to change.
Forward-looking statements. Statements regarding the Stiftung incorporation, the Q4 2027 Cell pre-sale, the Q2 2028 genesis, and the future behavior of the protocol are forward-looking. They reflect current expectations and are subject to risks, uncertainties, and changes — including counsel review, regulatory pre-rulings, technical feasibility, market conditions, and the discretion of the Stiftungsrat once seated. Actual outcomes may differ materially.
Jurisdiction. Nothing on this page is directed at, or intended for, residents of any jurisdiction where its publication, availability, or use would be unlawful — including persons or entities listed under OFAC, EU, UK, or Swiss SECO sanctions programmes. The planned offering is intended to be made (a) outside the United States under Regulation S, and (b) to verified accredited investors in the United States under Regulation D Rule 506(c). It will not be made to non-accredited US persons.
Cell classification. The Vault Cells are structured with the intent of supporting a Nutzungstoken (utility-token) classification under FINMA's 2018 ICO Guidelines and the 2019 Stablecoin Supplement — built around utility-at-issuance, a conjunctive transferability lock, and a per-buyer cap of two Cells. Final classification is subject to a FINMA pre-ruling and counsel review and is not yet final.
Foundation status. The TRELYAN Foundation is in formation as a Swiss Stiftung in Zug under articles 80 to 89-bis of the Swiss Civil Code. Upon registration at Handelsregister Zug it will be supervised by the Eidgenössische Stiftungsaufsicht. Founder personal capital invested in the project is zero by signed-and-witnessed Section 3 commitment.
Trademark. TRELYAN™ — Swiss trademark application 08601/2026 (IGE Zürich, filed 19 May 2026), pending registration.